Featured video: Prof. Jelle Barentsz (RadboudUMC, the Netherlands) is questioned by Prof. Jochen Walz (Institut Paoli-Calmettes, France) and Prof. Arnaud Villers (University of Lille Nord de France) about his study on the role of (fast) bi-parametric MRI versus multi-parametric MRI and TRUS-biopsy for detecting clinically significant prostate cancer in biopsy-naïve men with elevated PSA .
Posted on
Previous Article
« Enzalutamide plus ADT improves outcomes for metastatic hormone-sensitive prostate cancer Next Article
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease »
« Enzalutamide plus ADT improves outcomes for metastatic hormone-sensitive prostate cancer Next Article
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease »
Table of Contents: EAU 2019
Featured articles
Prostate Cancer
Barentsz Trial – Bi-parametric MRI versus multi-parametric MRI
Enzalutamide plus ADT improves outcomes for metastatic hormone-sensitive prostate cancer
Prostate cancer active surveillance: Better patient risk stratification and use of imaging
The role of pelvic lymph node dissection in prostate cancer: Extended vs standard
When to use imaging and imaging-guided therapies
Radioguided surgery is the future?
Bladder Cancer
Largest safety study of its kind with atezolizumab in metastatic bladder cancer
Bladder cancer risk and early detection
Consensus treatment pathway for patients with limited pelvic lymph node involvement in otherwise localised bladder cancer
FGFR3 gene mutation: Favourable prognostic impact in bladder cancer
Bladder cancer in young patients
Spanish study directly links surgical volume with mortality in bladder cancer patients undergoing cystectomy
Updated interim results of phase 2 trial of pembrolizumab for high-risk NMIBC unresponsive to BCG
Robot-assisted radical cystectomy or open radical cystectomy?
Renal Transplantation and Renal Cell Carcinoma
Andrology
Microdissection testicular sperm extraction (microTESE)
Male infertility/Premature ejaculation
Testosterone replacement therapy: Safe and maybe even protective
Focus on treatment of erectile dysfunction and Peyronie’s disease
Penile prosthesis implantation
Functional Urology
Decision aids are too difficult for patients
Lower Urinary Tract Symptoms
The Urodynamics for Prostate Surgery Trial
Minimally invasive surgical techniques must compete against pharmacotherapy in benign prostate hyperplasia (BPH)
Related Articles
August 31, 2021
PSMA PET-CT more accurate than standard-of-care imaging in RCC
January 25, 2023
Looking Forward to 2023: Anticipated Medical Innovations
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com